Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Zelira Therapeutics.
RELATED STOCKHEAD STORIES
Health & Biotech
Biotech: Cynata wins first round against sepsis bugs
Health & Biotech
Cannabis: THC Global hits milestone with first cannabis production at Southport
Health & Biotech
Weed Week: Wait till cannabis is legalised federally in the US – big pharma are already dreading it
Health & Biotech
Health: China loves Aussie food, maybe next it’ll love MVP’s Green Whistle too
Health & Biotech
Weed Week: In Thailand you’ll be able to grow cannabis ‘like any other herb’
Health & Biotech
With M&A heating up in Aus cannabis, is it international land grab time?
Health & Biotech
The life sciences investment wave is building. Here’s how to ride it.
Health & Biotech
“We’re creating something the world doesn’t have”: Zelda boss on US merger
Health & Biotech
‘People want revenues and a genuine business’: how ASX pot stocks are maturing
News
Rise & Shine: What you need to know before the ASX opens
Health & Biotech
Weed Week: G-men getting on the hype train
Health & Biotech
How do you get patients to accept cannabis? Treat it like any other medicine
Experts
Money Talks: Cannabis could ‘easily’ be a $200b-plus market
News
Weed Week: Oz gets serious with medical marijuana, new clinics rolling out soon
News
Weed Week: US looks at ways to help cannabis players get banking access
News
Weed week: cannabis is about to get scary in Canada
Health & Biotech